It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EXEL’s FA Score shows that 1 FA rating(s) are green whileTHRM’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EXEL’s TA Score shows that 5 TA indicator(s) are bullish while THRM’s TA Score has 4 bullish TA indicator(s).
EXEL (@Biotechnology) experienced а +1.72% price change this week, while THRM (@Auto Parts: OEM) price change was +5.69% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.33%. For the same industry, the average monthly price growth was +14.94%, and the average quarterly price growth was +30.68%.
The average weekly price growth across all stocks in the @Auto Parts: OEM industry was +3.36%. For the same industry, the average monthly price growth was +9.29%, and the average quarterly price growth was +23.98%.
EXEL is expected to report earnings on Nov 04, 2025.
THRM is expected to report earnings on Oct 29, 2025.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Auto Parts: OEM (+3.36% weekly)OEM or Original Equipment Manufacturer of auto parts refers to the original producer of a vehicles components, and so OEM car parts are usually identical to the parts used in producing the vehicle in the first place. OEM parts tend to fit the specifications of a particular model, and their compatibility is often guaranteed by the automaker itself. OEM parts could be more expensive to buy (compared to other vendors’ products) when a consumer goes for replacement. However, increased competition from aftermarket parts/third-party vendors could, in some cases, keep EOM prices in check. The industry might progress further in adopting newer technologies like 3D printing to boost supply chain performance and quality. Aptiv PLC, Magna International Inc. and BorgWarner Inc. are major OEMs for autos.
EXEL | THRM | EXEL / THRM | |
Capitalization | 10.4B | 1.13B | 924% |
EBITDA | 782M | 128M | 611% |
Gain YTD | 15.646 | -6.900 | -227% |
P/E Ratio | 18.51 | 36.80 | 50% |
Revenue | 2.23B | 1.45B | 153% |
Total Cash | 791M | 128M | 618% |
Total Debt | 180M | 270M | 67% |
EXEL | THRM | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 62 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 69 Overvalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 36 | 100 | |
SMR RATING 1..100 | 33 | 85 | |
PRICE GROWTH RATING 1..100 | 61 | 47 | |
P/E GROWTH RATING 1..100 | 73 | 15 | |
SEASONALITY SCORE 1..100 | 41 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
THRM's Valuation (68) in the Auto Parts OEM industry is in the same range as EXEL (69) in the Biotechnology industry. This means that THRM’s stock grew similarly to EXEL’s over the last 12 months.
EXEL's Profit vs Risk Rating (36) in the Biotechnology industry is somewhat better than the same rating for THRM (100) in the Auto Parts OEM industry. This means that EXEL’s stock grew somewhat faster than THRM’s over the last 12 months.
EXEL's SMR Rating (33) in the Biotechnology industry is somewhat better than the same rating for THRM (85) in the Auto Parts OEM industry. This means that EXEL’s stock grew somewhat faster than THRM’s over the last 12 months.
THRM's Price Growth Rating (47) in the Auto Parts OEM industry is in the same range as EXEL (61) in the Biotechnology industry. This means that THRM’s stock grew similarly to EXEL’s over the last 12 months.
THRM's P/E Growth Rating (15) in the Auto Parts OEM industry is somewhat better than the same rating for EXEL (73) in the Biotechnology industry. This means that THRM’s stock grew somewhat faster than EXEL’s over the last 12 months.
EXEL | THRM | |
---|---|---|
RSI ODDS (%) | 2 days ago79% | 2 days ago73% |
Stochastic ODDS (%) | 2 days ago58% | 2 days ago78% |
Momentum ODDS (%) | 2 days ago69% | 2 days ago64% |
MACD ODDS (%) | 2 days ago75% | 2 days ago64% |
TrendWeek ODDS (%) | 2 days ago66% | 2 days ago65% |
TrendMonth ODDS (%) | 2 days ago58% | 2 days ago60% |
Advances ODDS (%) | 2 days ago64% | 2 days ago65% |
Declines ODDS (%) | 4 days ago62% | 8 days ago71% |
BollingerBands ODDS (%) | 2 days ago84% | 2 days ago86% |
Aroon ODDS (%) | 2 days ago51% | 2 days ago56% |
A.I.dvisor indicates that over the last year, EXEL has been loosely correlated with JAZZ. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if EXEL jumps, then JAZZ could also see price increases.
Ticker / NAME | Correlation To EXEL | 1D Price Change % | ||
---|---|---|---|---|
EXEL | 100% | +0.44% | ||
JAZZ - EXEL | 35% Loosely correlated | -0.46% | ||
TECH - EXEL | 33% Poorly correlated | -1.00% | ||
MRSN - EXEL | 32% Poorly correlated | -0.26% | ||
ORMP - EXEL | 32% Poorly correlated | +4.25% | ||
AXON - EXEL | 31% Poorly correlated | +0.09% | ||
More |
A.I.dvisor indicates that over the last year, THRM has been closely correlated with LEA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if THRM jumps, then LEA could also see price increases.
Ticker / NAME | Correlation To THRM | 1D Price Change % | ||
---|---|---|---|---|
THRM | 100% | +0.73% | ||
LEA - THRM | 69% Closely correlated | +0.34% | ||
ADNT - THRM | 68% Closely correlated | +1.51% | ||
BWA - THRM | 67% Closely correlated | -0.07% | ||
VC - THRM | 66% Closely correlated | -0.70% | ||
MGA - THRM | 65% Loosely correlated | -0.13% | ||
More |